Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association

[1]  E. Donadi,et al.  The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes , 2010, Genes and Immunity.

[2]  M. Alary,et al.  Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. , 2010, Human immunology.

[3]  S. Giuliatti,et al.  In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. , 2009, Human immunology.

[4]  Wei Zhang,et al.  Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance. , 2009, Human immunology.

[5]  G. Ribas,et al.  HLA‐G 3′‐UTR SNP and 14‐bp deletion polymorphisms in Portuguese and Guinea‐Bissau populations , 2009, International journal of immunogenetics.

[6]  Sergio E Baranzini,et al.  The genetics of autoimmune diseases: a networked perspective. , 2009, Current opinion in immunology.

[7]  R. Viebahn,et al.  Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. , 2009, Human immunology.

[8]  P. Moreau,et al.  RREB-1 Is a Transcriptional Repressor of HLA-G1 , 2009, The Journal of Immunology.

[9]  A. Arnaiz-Villena,et al.  Evolution of major histocompatibility complex G and C and natural killer receptors in primates. , 2009, Human immunology.

[10]  N. Rouas-Freiss,et al.  Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. , 2009, Human immunology.

[11]  S. M. C. Jacques,et al.  HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. , 2009, Tissue antigens.

[12]  A. Lin,et al.  The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children. , 2009, Tissue antigens.

[13]  J. Peña,et al.  14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. , 2009, Human immunology.

[14]  Robert H. K. Eng,et al.  Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery , 2009, AIDS.

[15]  E. Donadi,et al.  Genetic Susceptibility Loci in Rheumatoid Arthritis Establish Transcriptional Regulatory Networks with Other Genes , 2009, Annals of the New York Academy of Sciences.

[16]  Shiyong Chen,et al.  Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. , 2009, The Journal of infectious diseases.

[17]  Y. Chan,et al.  Possible Gene-Gene Interaction of KIR2DL4 With its Cognate Ligand HLA-G in Modulating Risk for Preeclampsia , 2009, Reproductive Sciences.

[18]  E. Donadi,et al.  HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus , 2009, Modern Pathology.

[19]  C. Tremblay,et al.  Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection , 2009, AIDS.

[20]  M. Bouvier,et al.  MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.

[21]  P. Moreau,et al.  Non-classical transcriptional regulation of HLA-G: an update , 2009, Journal of cellular and molecular medicine.

[22]  E. Donadi,et al.  HLA-G Expression in the Skin of Patients with Systemic Sclerosis , 2009, The Journal of Rheumatology.

[23]  N. Rouas-Freiss,et al.  Immunohistochemical Study of HLA‐G Expression in Lung Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  K. Clemente,et al.  HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. , 2009, Transplantation proceedings.

[25]  J. Strominger,et al.  HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells , 2009, Proceedings of the National Academy of Sciences.

[26]  M. Faucher,et al.  Identification of six new HLA-G alleles with non-coding DNA base changes. , 2009, Tissue antigens.

[27]  J. Lubiński,et al.  HLA-G polymorphism and in vitro fertilization failure in a Polish population. , 2009, Tissue antigens.

[28]  A. Delgado-Cañedo,et al.  Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus , 2009, Lupus.

[29]  J. Chies,et al.  Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression. , 2009, Transplant immunology.

[30]  S. Crovella,et al.  Association between HLA-G 3′UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children , 2009, AIDS.

[31]  M. Faucher,et al.  Characterisation of five novel HLA-G alleles with coding DNA base changes. , 2008, Tissue antigens.

[32]  S. Yie,et al.  A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. , 2008, Molecular human reproduction.

[33]  C. Carcassi,et al.  HLA-G Gene Polymorphism in Human Placentas: Possible Association of G*0106 Allele with Preeclampsia and Miscarriage , 2008, Biology of reproduction.

[34]  David M. Conrad,et al.  Quantitative HLA-G Expression in Metastasising and Non-Metastasising Primary Thin Cutaneous Melanomas , 2008, Dermatology.

[35]  E. Donadi,et al.  HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. , 2008, Tissue antigens.

[36]  R. Apps,et al.  A critical look at HLA-G. , 2008, Trends in immunology.

[37]  M. Rubini,et al.  HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. , 2008, Tissue antigens.

[38]  N. Rouas-Freiss,et al.  Beyond the increasing complexity of the immunomodulatory HLA-G molecule. , 2008, Blood.

[39]  M. Alary,et al.  Differences in immunoregulatory cytokine expression patterns in the systemic and genital tract compartments of HIV-1-infected commercial sex workers in Benin , 2008, Mucosal Immunology.

[40]  Y. Chan,et al.  Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies. , 2008, Molecular human reproduction.

[41]  V. Rao,et al.  Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  L. Schuler‐Faccini,et al.  Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. , 2008, Tissue antigens.

[43]  Philippe Moreau,et al.  HLA-G: from biology to clinical benefits. , 2008, Trends in immunology.

[44]  E. Donadi,et al.  Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. , 2008, Transplant immunology.

[45]  E. Granieri,et al.  CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing—remitting multiple sclerosis , 2008, Multiple sclerosis.

[46]  S. Wagner,et al.  HLA-G expression in malignant melanoma. , 2007, Seminars in cancer biology.

[47]  B. Seliger,et al.  Structure, expression and function of HLA-G in renal cell carcinoma. , 2007, Seminars in cancer biology.

[48]  M. Zhu,et al.  HLA-G expression in human ovarian carcinoma counteracts NK cell function. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  J. Lubiński,et al.  HLA-G polymorphism in a Polish population and reproductive failure. , 2007, Tissue antigens.

[50]  E. Donadi,et al.  Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. , 2007, Tissue antigens.

[51]  Carole Ober,et al.  Allele-specific targeting of microRNAs to HLA-G and risk of asthma. , 2007, American journal of human genetics.

[52]  E. Donadi,et al.  Absence of the HLA‐G*0105N allele in Amerindian populations from the Brazilian Amazon Region: a possible role of natural selection , 2007 .

[53]  E. Donadi,et al.  Absence of the HLA-G*0105N allele in Amerindian populations from the Brazilian Amazon Region: a possible role of natural selection. , 2007, Tissue antigens.

[54]  C. Carcassi,et al.  The human leucocyte antigen‐G 14‐basepair polymorphism correlates with graft‐versus‐host disease in unrelated bone marrow transplantation for thalassaemia , 2007, British journal of haematology.

[55]  S. Mello,et al.  Profiling Meta‐Analysis Reveals Primarily Gene Coexpression Concordance between Systemic Lupus Erythematosus and Rheumatoid Arthritis , 2007, Annals of the New York Academy of Sciences.

[56]  E. Donadi,et al.  HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. , 2007, Tissue antigens.

[57]  Hong Yang,et al.  Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma , 2007, Annals of Surgical Oncology.

[58]  H. Wiendl,et al.  The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis. , 2007, Human immunology.

[59]  J. Lozano,et al.  Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. , 2007, Human immunology.

[60]  A. Carpentier,et al.  Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[61]  J. McCluskey,et al.  Structural studies on HLA-G: implications for ligand and receptor binding. , 2007, Human immunology.

[62]  N. Rouas-Freiss,et al.  Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. , 2007, Human immunology.

[63]  P. Moreau,et al.  Trogocytosis‐based generation of suppressive NK cells , 2007, The EMBO journal.

[64]  A. Fazleabas,et al.  Polymorphisms in the Paan-AG promoter influence NF-κB binding and transcriptional activity , 2007, Immunogenetics.

[65]  I. Joosten,et al.  Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. , 2007, Molecular human reproduction.

[66]  Sylvie C. Fail,et al.  The IMGT/HLA and IPD databases , 2006, Human mutation.

[67]  J. Lozano,et al.  sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. , 2006, Transplant immunology.

[68]  F. Gros,et al.  Elevated levels of soluble non‐classical major histocompatibility class I molecule human leucocyte antigen (HLA)‐G in the blood of HIV‐infected patients with or without visceral leishmaniasis , 2006, Clinical and experimental immunology.

[69]  Robert D. Schreiber,et al.  Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.

[70]  E. Carosella,et al.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. , 2006, Blood.

[71]  Kouhei Tsumoto,et al.  Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) , 2006, Proceedings of the National Academy of Sciences.

[72]  V. Bond,et al.  HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission , 2006, AIDS research and therapy.

[73]  S. Yie,et al.  Progesterone regulates HLA-G gene expression through a novel progesterone response element. , 2006, Human reproduction.

[74]  K. L. Sharpe-Timms,et al.  Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. , 2006, Gynecologic oncology.

[75]  E. Carosella,et al.  Soluble HLA‐G Expression and Renal Graft Acceptance , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[76]  M. Rubini,et al.  HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis , 2006, Pharmacogenetics and genomics.

[77]  C. Ober,et al.  The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. , 2006, Human reproduction.

[78]  S. Natsugoe,et al.  HLA-G expression in gastric cancer. , 2006, Anticancer research.

[79]  T. Hviid.  HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. , 2006, Human reproduction update.

[80]  B. Torbett,et al.  The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G , 2006, Diabetes.

[81]  Kouhei Tsumoto,et al.  Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer* , 2006, Journal of Biological Chemistry.

[82]  J. Peña,et al.  Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. , 2006, Human immunology.

[83]  M. Martinetti,et al.  Hierarchy of Baby-Linked Immunogenetic Risk Factors in the Vertical Transmission of Hepatitis C Virus , 2006, International journal of immunopathology and pharmacology.

[84]  B. Branger,et al.  Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. , 2006, Neoplasia.

[85]  M. Haberal,et al.  Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. , 2006, Transplantation proceedings.

[86]  R. Loewenthal,et al.  HLA-G levels in serum and plasma. , 2006, Tissue antigens.

[87]  Y. Ge,et al.  HLA‐G polymorphism in a Chinese Han population with recurrent spontaneous abortion , 2006, International journal of immunogenetics.

[88]  J. Hargrove,et al.  Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. , 2006, The Journal of infectious diseases.

[89]  S. Brennecke,et al.  The −56T HLA-G Promoter Polymorphism is Not Associated with Pre-eclampsia/Eclampsia in Australian and New Zealand Women , 2006, Hypertension in pregnancy.

[90]  Ayshwarya Subramanian,et al.  Retinoblastoma: Expression of HLA-G , 2006, Ocular immunology and inflammation.

[91]  S. Agrawal,et al.  Non-Classical HLA-G Antigen and Its Role in the Cancer Progression , 2006, Cancer investigation.

[92]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[93]  N. Rouas-Freiss,et al.  Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections , 2005, Journal of Virology.

[94]  C. Ober,et al.  Evidence of balancing selection at the HLA-G promoter region. , 2005, Human molecular genetics.

[95]  R. Bataille,et al.  Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance , 2005, Clinical Cancer Research.

[96]  H. Achdout,et al.  The CD85J/Leukocyte Inhibitory Receptor-1 Distinguishes between Conformed and β2-Microglobulin-Free HLA-G Molecules1 , 2005, The Journal of Immunology.

[97]  T. Jensen,et al.  Formation of export-competent mRNP: escaping nuclear destruction. , 2005, Current opinion in cell biology.

[98]  U. Nehrbass,et al.  Quality control of messenger ribonucleoprotein particles in the nucleus and at the pore. , 2005, Current opinion in cell biology.

[99]  A. Aguilera.  Cotranscriptional mRNP assembly: from the DNA to the nuclear pore. , 2005, Current opinion in cell biology.

[100]  N. Rouas-Freiss,et al.  HLA‐G gene activation in tumor cells involves cis‐acting epigenetic changes , 2005, International journal of cancer.

[101]  Wei-Hua Yan,et al.  Residues Met76 and Gln79 in HLA-G α1 domain involved in KIR2DL4 recognition , 2005, Cell Research.

[102]  Daniel H. Schneider,et al.  Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. , 2005, American journal of human genetics.

[103]  S. Agrawal,et al.  Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[104]  J. Trowsdale,et al.  The LILR family: modulators of innate and adaptive immune pathways in health and disease. , 2004, Tissue antigens.

[105]  E. Sheiner,et al.  HLA-G Antigen and Parturition: Maternal Serum, Fetal Serum and Amniotic Fluid Levels during Pregnancy , 2004, Fetal Diagnosis and Therapy.

[106]  O. Christiansen,et al.  Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. , 2004, Tissue antigens.

[107]  O. Christiansen,et al.  HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms , 2004, Immunogenetics.

[108]  Federico Garrido,et al.  The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape , 2004, Cancer Immunology, Immunotherapy.

[109]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[110]  B. Ward,et al.  Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women , 2004, AIDS.

[111]  Eunkyung Kim,et al.  Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. , 2004, Biochemical and biophysical research communications.

[112]  J. Dausset,et al.  In vivo, RFX5 binds differently to the human leucocyte antigen‐E, ‐F, and ‐G gene promoters and participates in HLA class I protein expression in a cell type‐dependent manner , 2004, Immunology.

[113]  J. Lozano,et al.  HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. , 2003, Human immunology.

[114]  Philippe Moreau,et al.  The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. , 2003, Human immunology.

[115]  D. Chan,et al.  HLA-G is a potential tumor marker in malignant ascites. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[116]  J. Dausset,et al.  Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. , 2003, Journal of hepatology.

[117]  J. McCluskey,et al.  Biology and functions of human leukocyte antigen-G in health and sickness. , 2003, Tissue antigens.

[118]  S. Kuersten,et al.  The power of the 3′ UTR: translational control and development , 2003, Nature Reviews Genetics.

[119]  Kouhei Tsumoto,et al.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[120]  C. Ober,et al.  Variation in the HLA-G promoter region influences miscarriage rates. , 2003, American journal of human genetics.

[121]  T. Hviid,et al.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels , 2003, Immunogenetics.

[122]  K. Ahn,et al.  An Essential Function of Tapasin in Quality Control of HLA-G Molecules* , 2003, The Journal of Biological Chemistry.

[123]  Yang Shi,et al.  Coordinated histone modifications mediated by a CtBP co-repressor complex , 2003, Nature.

[124]  B. Seliger,et al.  HLA-G and MIC expression in tumors and their role in anti-tumor immunity. , 2003, Trends in immunology.

[125]  J. Dausset,et al.  HLA-G gene repression is reversed by demethylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[126]  S. Ferrone,et al.  Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation , 2003, European journal of immunology.

[127]  B. Ward,et al.  Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-1. , 2002, AIDS.

[128]  K. Hsu,et al.  The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.

[129]  J. Strominger,et al.  Disulfide bond-mediated dimerization of HLA-G on the cell surface , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[130]  P. J. van den Elsen,et al.  HLA-G Transactivation by cAMP-response Element-binding Protein (CREB) , 2002, The Journal of Biological Chemistry.

[131]  Bert W O'Malley,et al.  Coordinate Regulation of Transcription and Splicing by Steroid Receptor Coregulators , 2002, Science.

[132]  B. Ward,et al.  HLA-G exhibits low level of polymorphism in indigenous East Africans. , 2002, Human immunology.

[133]  E. Donadi,et al.  HLA‐DRB1, DQB1, and DQA1 Allele Profile in Brazilian Patients with Type 1 Diabetes Mellitus , 2002, Annals of the New York Academy of Sciences.

[134]  J. Dausset,et al.  Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule , 2002, AIDS.

[135]  F. Puppo,et al.  Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8 Cells by Fas/Fas-Ligand Interaction , 2002, TheScientificWorldJournal.

[136]  R. Dummer,et al.  HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. , 2002, Blood.

[137]  T. Hodge,et al.  Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. , 2001, AIDS.

[138]  S. Westerheide,et al.  The MHC-Specific Enhanceosome and Its Role in MHC Class I and β2-Microglobulin Gene Transactivation1 , 2001, The Journal of Immunology.

[139]  J. Dausset,et al.  Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease , 2001, Cellular and Molecular Life Sciences CMLS.

[140]  P. Le Bouteiller,et al.  HLA-G unique promoter region: functional implications , 2001, Immunogenetics.

[141]  J. Dausset,et al.  Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[142]  K. Ahn,et al.  The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. , 2001, Immunity.

[143]  S. Ugurel,et al.  Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon‐α immunotherapy , 2001 .

[144]  J. Dausset,et al.  A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β* , 2001, The Journal of Biological Chemistry.

[145]  M. Colonna,et al.  Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization1 , 2001, The Journal of Immunology.

[146]  J. Dausset,et al.  The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors. , 2000, Human immunology.

[147]  A. Arnaiz-Villena,et al.  Evolution of MHC-G in humans and primates based on three new 3'UT polymorphisms. , 2000, Human immunology.

[148]  J. Dausset,et al.  Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. , 2000, Human immunology.

[149]  B. Ward,et al.  HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. , 2000, Human immunology.

[150]  A. Arnaiz-Villena,et al.  Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. , 2000, Tissue antigens.

[151]  J. Dausset,et al.  Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines , 2000, Cell stress & chaperones.

[152]  P. André,et al.  Modulation of HLA-G Antigens Expression by Human Cytomegalovirus: Specific Induction in Activated Macrophages Harboring Human Cytomegalovirus Infection1 , 2000, The Journal of Immunology.

[153]  David I. Stuart,et al.  Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* , 2000, The Journal of Biological Chemistry.

[154]  W. Murphy,et al.  A candidate interferon-gamma activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins. , 1999, Human immunology.

[155]  R. Mantovani,et al.  The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.

[156]  A. Woltman,et al.  Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. , 1999, Journal of immunology.

[157]  J. Dausset,et al.  HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. , 1999, International immunology.

[158]  Anajane G. Smith,et al.  Re-examination of HLA-G polymorphism in African Americans , 1999, Immunogenetics.

[159]  A. Arnaiz-Villena,et al.  Evolution of MHC-G in primates: a different kind of molecule for each group of species. , 1999, Journal of reproductive immunology.

[160]  A. Martinho,et al.  HLA-G genetic polymorphism in 57 Portuguese white families studied by PCR-RFLP and PCR-SSOP. , 1999, Transplantation proceedings.

[161]  E. Carosella,et al.  IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. , 1999, International immunology.

[162]  J. Dausset,et al.  Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. , 1999, Placenta.

[163]  J. M. Boss,et al.  CREB regulates MHC class II expression in a CIITA-dependent manner. , 1999, Immunity.

[164]  J. M. Boss,et al.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. , 1999, Immunity.

[165]  M. Colonna,et al.  The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells , 1999, European journal of immunology.

[166]  A. Arnaiz-Villena,et al.  Description of two Mhc-C-related sequences in the New World monkey Saguinus oedipus. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[167]  R. Aebersold,et al.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients , 1998, Nature Genetics.

[168]  Y. Fukushima,et al.  Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. , 1998, International journal of molecular medicine.

[169]  P. J. van den Elsen,et al.  The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. , 1998, Journal of immunology.

[170]  A. Arnaiz-Villena,et al.  Description of a new kind of MHC DNA sequence in Saguinus oedipus (cotton-top tamarin). , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[171]  P. J. van den Elsen,et al.  Regulation of MHC class I and II gene transcription: differences and similarities , 1998, Immunogenetics.

[172]  A. Arnaiz-Villena,et al.  Transcription and weak expression of HLA-DRB6: a gene with anomalies in exon 1 and other regions. , 1998, Immunogenetics.

[173]  D. Krebs,et al.  HLA-G polymorphisms and allele frequencies in Caucasians. , 1998, Human immunology.

[174]  J. Dausset,et al.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[175]  C. Ober,et al.  HLA-G1 protein expression is not essential for fetal survival. , 1998, Placenta.

[176]  C. Ober,et al.  HLA-G polymorphisms: neutral evolution or novel function? , 1997, Journal of reproductive immunology.

[177]  A. Peijnenburg,et al.  Site α Is Crucial for Two Routes of IFNγ-Induced MHC Class I Transactivation: The ISRE-Mediated Route and a Novel Pathway Involving CIITA , 1997 .

[178]  A. Arnaiz-Villena,et al.  Allelic diversity at the primate Mhc-G locus: exon 3 bears stop codons in all Cercopithecinae sequences. , 1997, Immunogenetics.

[179]  P. Emery,et al.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency , 1997, The EMBO journal.

[180]  C. Ober,et al.  Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A1. , 1996, Journal of reproductive immunology.

[181]  J. She.  Susceptibility to type I diabetes: HLA-DQ and DR revisited. , 1996, Immunology today.

[182]  D. Bedwell,et al.  Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations , 1996, Nature Medicine.

[183]  H. Rammensee,et al.  Nonclassical HLA-G molecules are classical peptide presenters , 1996, Current Biology.

[184]  J. Bajorath,et al.  The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. , 1995, Immunity.

[185]  B. Durand,et al.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). , 1995, Genes & development.

[186]  D. Geraghty,et al.  A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. , 1994, Journal of immunology.

[187]  L. Peltonen,et al.  Characterization of a point mutation in aspartylglucosaminidase gene: evidence for a readthrough of a translational stop codon. , 1994, Human molecular genetics.

[188]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[189]  D. Cooper,et al.  A 14 bp deletion polymorphism in the HLA-G gene. , 1993, Human molecular genetics.

[190]  H. Orr,et al.  Cellular distribution of HLA-G mRNA in transgenic mouse placentas. , 1993, Journal of immunology.

[191]  M. Athanasiou,et al.  Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription. , 1993, Journal of immunology.

[192]  D. Geraghty,et al.  Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[193]  A. Hughes,et al.  Evolution of the MHC class I genes of a New World primate from ancestral homologues of human non-classical genes , 1990, Nature.

[194]  A. Hughes,et al.  Molecular cloning of cDNA that encode MHC class I molecules from a New World primate (Saguinus oedipus). Natural selection acts at positions that may affect peptide presentation to T cells. , 1990, Journal of immunology.

[195]  H. Orr,et al.  A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[196]  K. Humphreys,et al.  Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B , 2009, Genes and Immunity.

[197]  M. Bicalho,et al.  A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. , 2009, Transplant immunology.

[198]  M. Citores,et al.  Expression of human leukocyte antigen-G in systemic lupus erythematosus. , 2008, Human immunology.

[199]  J. Lubiński,et al.  Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure. , 2007, Folia histochemica et cytobiologica.

[200]  E. Carosella,et al.  HLA-G and cancer. , 2007, Seminars in cancer biology.

[201]  R. Rizzo,et al.  Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. , 2006, Human immunology.

[202]  H. Kaneku.  Detection of soluble HLA-G and its correlation with kidney transplant outcome. , 2006, Clinical transplants.

[203]  A. Arnaiz-Villena,et al.  Allelic diversity at the primateMhc-G locus: Exon 3 bears stop codons in allCercophitecinae sequences , 2005, Immunogenetics.

[204]  Wei-Hua Yan,et al.  Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. , 2005, Cell research.

[205]  J. Dausset,et al.  HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. , 2003, Advances in immunology.

[206]  D. Krebs,et al.  Association of soluble HLA-G plasma levels with HLA-G alleles. , 2001, Tissue antigens.

[207]  W. Tilgen,et al.  Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. , 2001, Cancer.

[208]  A. Sharkey,et al.  Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. , 1999, Tissue antigens.

[209]  A. Arnaiz-Villena,et al.  A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population , 1997, Immunogenetics.

[210]  A. Arnaiz-Villena,et al.  Primate Mhc-E and -G alleles , 1997, Immunogenetics.

[211]  P. J. van den Elsen,et al.  Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. , 1997, Immunity.